Pharmatech Logo
Advancing Complex Science Through Precision and Innovation

research & development

Advancing Complex Science Through Precision and Innovation

Turning health challenges into pioneering solutions for a healthier tomorrow.

Powered by Leading Scientists, chemists & analysts, our R&D ensures reliable transition from development to commercial production.

R&D PHILOSOPHY

Building Science That Translates Into Real-World Impact

At Gufic, our R&D is driven by strong scientific expertise and continuous innovation, with a clear focus on developing new products, improving existing solutions, and advancing specialized drug delivery systems.

Our work spans new formulations and molecules, along with continuous enhancement of processes and systems. We introduce technologies that improve efficacy, bioavailability, and potency, with a strong emphasis on advanced drug delivery and lyophilized products.

Through strategic collaborations and active patent development, including process and herbal patents, we strengthen our capabilities while ensuring consistent quality, scalability, and reliable performance across all solutions.

Building Science That Translates Into

Scientific Innovation

Core R&D Capabilities

Developing complex APIs, advanced delivery systems, and scalable processes through precision-driven research and technical expertise.

Complex API Development

Complex API Development

Expertise in developing complex generic APIs through advanced synthesis and multi-step reaction systems.

Drug Delivery Innovation

Drug Delivery Innovation

Designing advanced delivery systems that improve usability, accuracy, and treatment efficiency.

Analytical Precision

Analytical Precision

Driving quality and consistency through advanced analytical capabilities and rigorous evaluation.

FUTURE FOCUS

Advancing Accessible and Complex Therapeutics

Our R&D strategy focuses on developing novel, affordable complex generics across critical therapeutic categories.Key areas include β-lactamase inhibitors, antifungal and antibacterial therapies, GABA receptor-based treatments, and complex peptide APIs such as GnRH agonists and antagonists.

With a strong emphasis on scalability, affordability, and accessibility, we aim to expand the reach of advanced therapies while upholding the highest standards of quality, compliance, and innovation.

Advancing Accessible and